Since approval, the stock is down 23%. Why? Momenta is making a ton of money right now and nobody knows if Teva ever willget approval or not. The analysis, Tim from Stanford Berkstein didn't even know. He only gave the same beliefs stated during Teva's conference call. That idiot only hampered this stock at a discounted rate.